A GlobalData analyst has warned that Trump's second term could see major changes in US healthcare, and RFK could rock the ...

The two health insurance giants, with a combined market value of roughly $125 billion, held talks about a deal last year.

Cold water has been tossed on the idea that CVS Health would break up the company and sell off health or pharmacy benefits from assets that provide medical care. In his first earnings call following a ...

States may be getting ready to crack down even harder on pharmacy benefit managers. The National Association of Insurance ...

Part 1 of this 3-part series for Global Biosimilars Week focuses on legal barriers to biosimilar access in the US, including the patent system, and discusses ongoing legislative efforts to address ...

This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their ...

The story was too "uncomfortable" for local MSM to cover so instead our progressive local news outlet blame shifts pharmacy ...

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

Donald Trump will be the 47th President of the U.S. Not since 1892 has a President been elected to two non-consecutive terms, ...